IL13RA2 and central nervous system cancer: In the orthotopic glioma xenograft mouse model, IL13Rα2 CAR T cells that were also designed to express IL-15 exhibited elevated anti-glioma activity, enhanced persistence, and considerably longer survival than the control [159].